Related Experiment Videos
A new approach to drug penetration study
M Kojima1, O Hockwin, K Sasaki
1Department of Ophthalmology, Kanazawa Medical University, Ishikawa, Japan.
Lens and Eye Toxicity Research
|January 1, 1992
Summary
Aldose reductase inhibitor (AL-04114) primarily penetrates the shallow cortex and equator of the eye lens. This drug distribution study in bovine lens cultures and rabbit eyes shows limited penetration into deeper lens layers and no vitreous humor presence.
Area of Science:
- Ophthalmology
- Pharmacology
- Drug Delivery
Background:
- Aldose reductase inhibitors (ARIs) are investigated for ocular conditions.
- Understanding drug penetration and distribution in the eye is crucial for effective treatment.
Purpose of the Study:
- To determine the ocular penetration and distribution of the ARI AL-04114 within the lens.
- To map the drug's localization in different lens layers using in vitro and in vivo models.
Main Methods:
- In vitro study using bovine lens organ cultures incubated with AL-04114.
- In vivo study involving topical administration of AL-04114 ophthalmic solution to rabbit eyes.
- Micro lens sectioning and reversed-phase HPLC analysis to quantify drug concentration in various lens sections, aqueous humor, and vitreous humor.
Main Results:
- In vitro, AL-04114 concentration was highest in the posterior shallow cortex, followed by the equator and anterior shallow cortex.
- No in vitro drug penetration was observed in the deeper cortex or nucleus.
- In vivo, AL-04114 penetrated the equator and anterior shallow cortex, but not deeper layers, nucleus, or vitreous humor.
- Drug was detected in serum and aqueous humor.
Conclusions:
- AL-04114 demonstrates limited penetration into the deeper structures of the eye lens.
- The drug primarily distributes within the anterior and equatorial regions of the lens cortex.
- Further research may be needed to enhance penetration into deeper ocular tissues.